Probing_VBG substrate_NN binding_VBG to_TO Metallo-beta-Lactamase_NP L1_NP from_IN Stenotrophomonas_NP maltophilia_NN by_IN using_VBG site-directed_JJ mutagenesis_NN Abstract_NP |_SYM Background_NN |_SYM The_DT metallo-beta-lactamases_NNS are_VBP Zn(II)-containing_VBG enzymes_NNS that_WDT hydrolyze_VBP the_DT beta-lactam_NN bond_NN in_IN penicillins_NNS ,_, cephalosporins_NNS ,_, and_CC carbapenems_NNS and_CC are_VBP involved_VBN in_IN bacterial_JJ antibiotic_JJ resistance_NN ._SENT There_EX are_VBP at_IN least_JJS 20_CD distinct_JJ organisms_NNS that_WDT produce_VBP a_DT metallo-beta-lactamase_NN ,_, and_CC these_DT enzymes_NNS have_VBP been_VBN extensively_RB studied_VBN using_VBG X-ray_NN crystallographic_JJ ,_, computational_JJ ,_, kinetic_JJ ,_, and_CC inhibition_NN studies_NNS ;_: however_RB ,_, much_RB is_VBZ still_RB unknown_JJ about_IN how_WRB substrates_NNS bind_VBP and_CC the_DT catalytic_JJ mechanism_NN ._SENT In_IN an_DT effort_NN to_TO probe_VB substrate_NN binding_JJ to_TO metallo-beta-lactamase_VB L1_NP from_IN Stenotrophomonas_NP maltophilia_NP ,_, nine_CD site-directed_JJ mutants_NNS of_IN L1_NP were_VBD prepared_VBN and_CC characterized_VBN using_VBG metal_NN analyses_NNS ,_, CD_NN spectroscopy_NN ,_, and_CC pre-steady_JJ state_NN and_CC steady_JJ state_NN kinetics_NNS ._SENT Results_NNS |_SYM Site-directed_JJ mutations_NNS were_VBD generated_VBN of_IN amino_NN acids_NNS previously_RB predicted_VBD to_TO be_VB important_JJ in_IN substrate_NN binding_NN ._SENT Steady-state_NN kinetic_JJ studies_NNS using_VBG the_DT mutant_JJ enzymes_NNS and_CC 9_CD different_JJ substrates_NNS demonstrated_VBD varying_VBG Km_NP and_CC kcat_NN values_NNS for_IN the_DT different_JJ enzymes_NNS and_CC substrates_NNS and_CC that_IN no_DT direct_JJ correlation_NN between_IN Km_NP and_CC the_DT effect_NN of_IN the_DT mutation_NN on_IN substrate_NN binding_NN could_MD be_VB drawn_VBN ._SENT Stopped-flow_JJ fluorescence_NN studies_NNS using_VBG nitrocefin_NN as_IN the_DT substrate_NN showed_VBD that_IN only_RB the_DT S224D_NP and_CC Y228A_NP mutants_NNS exhibited_VBD weaker_JJR nitrocefin_NN binding_NN ._SENT Conclusions_NNS |_SYM The_DT data_NNS presented_VBD herein_RB indicate_VB that_IN Ser224_NP ,_, Ile164_NP ,_, Phe158_NP ,_, Tyr228_NP ,_, and_CC Asn233_NP are_VBP not_RB essential_JJ for_IN tight_JJ binding_NN of_IN substrate_NN to_TO metallo-beta-lactamase_NN L1_NP ._SENT The_DT results_NNS in_IN this_DT work_NN also_RB show_VBP that_IN Km_NP values_NNS are_VBP not_RB reliable_JJ for_IN showing_VBG substrate_NN binding_NN ,_, and_CC there_EX is_VBZ no_DT correlation_NN between_IN substrate_NN binding_NN and_CC the_DT amount_NN of_IN reaction_NN intermediate_NN formed_VBN during_IN the_DT reaction_NN ._SENT This_DT work_NN represents_VBZ the_DT first_JJ experimental_JJ testing_NN of_IN one_CD of_IN the_DT computational_JJ models_NNS of_IN the_DT metallo-beta-lactamases_NNS ._SENT The_DT overuse_NN of_IN antibiotics_NNS in_IN the_DT clinic_NN and_CC for_IN agricultural_JJ uses_NNS has_VBZ resulted_VBN in_IN a_DT tremendous_JJ selective_JJ pressure_NN for_IN antibiotic_JJ resistant_JJ bacteria_NNS ._SENT These_DT bacteria_NNS become_VBP resistant_JJ by_IN a_DT number_NN of_IN mechanisms_NNS ,_, such_JJ as_IN producing_VBG enzymes_NNS that_WDT hydrolyze_VBP or_CC inactivate_VBP the_DT antibiotics_NNS ,_, producing_VBG efflux_NN pumps_NNS that_WDT transport_VBP the_DT antibiotic_NN out_RP of_IN the_DT cell_NN ,_, or_CC modifying_VBG their_PP$ cell_NN wall_NN components_NNS so_IN they_PP no_DT longer_JJR bind_NN effectively_RB to_TO the_DT antibiotics_NNS ._SENT The_DT most_JJS common_NN ,_, least_JJS expensive_JJ ,_, and_CC effective_JJ antibiotics_NNS are_VBP the_DT beta-lactam_NN containing_VBG antibiotics_NNS ,_, such_JJ as_IN the_DT penicillins_NNS ,_, cephalosporins_NNS ,_, and_CC carbapenems_NNS ._SENT These_DT antibiotics_NNS are_VBP mechanism-based_JJ inhibitors_NNS of_IN transpeptidase_NN ,_, a_DT bacterial_JJ enzyme_NN required_VBN for_IN the_DT production_NN of_IN a_DT strong_JJ viable_JJ cell_NN wall_NN ._SENT In_IN response_NN to_TO the_DT widespread_JJ use_NN of_IN beta-lactam_NN containing_VBG antibiotics_NNS ,_, bacteria_NNS have_VBP acquired_VBN the_DT ability_NN to_TO produce_VB beta-lactamases_NNS ,_, which_WDT are_VBP enzymes_NNS that_WDT hydrolyze_VBP and_CC inactivate_VBP beta-lactam_NN containing_VBG antibiotics_NNS ._SENT There_EX are_VBP over_IN 300_CD distinct_JJ beta-lactamases_NNS known_VBN ,_, and_CC these_DT enzymes_NNS have_VBP been_VBN grouped_VBN by_IN a_DT number_NN of_IN classification_NN schemes_NNS ._SENT For_IN example_NN ,_, Bush_NP has_VBZ developed_VBN a_DT scheme_NN ,_, based_VBN on_IN the_DT enzymes_NNS '_POS molecular_JJ properties_NNS ,_, that_WDT has_VBZ four_CD distinct_JJ beta-lactamase_NN groups_NNS ._SENT One_CD of_IN the_DT more_JJR alarming_JJ groups_NNS are_VBP the_DT Bush_NP group_NN 3_CD enzymes_NNS ,_, which_WDT are_VBP Zn(II)_JJ dependent_JJ enzymes_NNS that_WDT hydrolyze_VBP nearly_RB all_DT known_VBN beta-lactam_NN containing_VBG antibiotics_NNS and_CC for_IN which_WDT there_EX are_VBP no_RB or_CC very_RB few_JJ known_VBN clinical_JJ inhibitors_NNS [_SYM ,,-_NN ]_SYM ._SENT The_DT metallo-beta-lactamases_NNS have_VBP been_VBN further_RBR divided_VBN by_IN Bush_NP into_IN subgroups_NNS based_VBN on_IN amino_NN acid_NN sequence_NN identity_NN :_: the_DT Ba_NP enzymes_NNS share_VBP a_DT >23_JJ %_NN sequence_NN identity_NN ,_, require_VBP 2_CD Zn(II)_NP ions_NNS for_IN full_JJ activity_NN ,_, prefer_VBP penicillins_NNS and_CC cephalosporins_NNS as_IN substrates_NNS ,_, and_CC are_VBP represented_VBN by_IN metallo-beta-lactamase_NN CcrA_NP from_IN Bacteroides_NP fragilis_NP ,_, the_DT Bb_NP enzymes_NNS share_VBP a_DT 11_CD %_NN sequence_NN identity_NN with_IN the_DT Ba_NP enzymes_NNS ,_, require_VB only_RB 1_CD Zn(II)_NP ion_NN for_IN full_JJ activity_NN ,_, prefer_VBP carbapenems_NNS as_IN substrates_NNS ,_, and_CC are_VBP represented_VBN by_IN the_DT metallo-beta-lactamase_NN imiS_NN from_IN Aeromonas_NP sobria_NN ,_, and_CC the_DT Bc_NP enzymes_NNS have_VBP only_RB 9_CD conserved_VBN residues_NNS with_IN the_DT other_JJ metallo-beta-lactamases_NNS ,_, require_VBP 2_CD Zn(II)_NP ions_NNS for_IN activity_NN ,_, contain_VBP a_DT different_JJ metal_NN binding_VBG motif_NN than_IN the_DT other_JJ metallo-beta-lactamases_NNS ,_, prefer_VBP penicillins_NNS as_IN substrates_NNS ,_, and_CC are_VBP represented_VBN by_IN the_DT metallo-beta-lactamase_NN L1_NP from_IN Stenotrophomonas_NP maltophilia_NN ._SENT A_DT similar_JJ grouping_NN scheme_NN (_( B1_NP ,_, B2_NN ,_, and_CC B3_NP )_) based_VBN on_IN structural_JJ properties_NNS of_IN the_DT metallo-beta-lactamases_NNS has_VBZ recently_RB been_VBN offered_VBN ._SENT The_DT diversity_NN of_IN the_DT group_NN 3_CD beta-lactamases_NNS is_VBZ best_RBS exemplified_VBN by_IN the_DT enzymes_NNS '_POS vastly_RB differing_VBG efficacies_NNS towards_IN non-clinical_JJ inhibitors_NNS ;_: these_DT differences_NNS predict_VBP that_IN one_CD inhibitor_NN may_MD not_RB inhibit_VB all_DT metallo-beta-lactamases_NNS [_SYM ,-_NN ]_SYM ._SENT To_TO combat_VB this_DT problem_NN ,_, we_PP are_VBP characterizing_VBG a_DT metallo-beta-lactamase_NN from_IN each_DT of_IN the_DT subgroups_NNS in_IN an_DT effort_NN to_TO identify_VB a_DT common_JJ structural_JJ or_CC mechanistic_JJ aspect_NN of_IN the_DT enzymes_NNS that_WDT can_MD be_VB targeted_VBN for_IN the_DT generation_NN of_IN an_DT inhibitor_NN ._SENT It_PP is_VBZ hoped_VBN that_IN this_DT inhibitor_NN ,_, when_WRB given_VBN in_IN combination_NN with_IN an_DT existing_JJ antibiotic_NN ,_, will_MD prove_VB to_TO be_VB an_DT effective_JJ therapy_NN against_IN bacteria_NNS that_WDT produce_VBP a_DT metallo-beta-lactamase_NN ._SENT This_DT work_NN describes_VBZ our_PP$ efforts_NNS on_IN metallo-beta-lactamase_NN L1_NP from_IN S._NP maltophilia_NN ._SENT S._NP maltophilia_NP is_VBZ an_DT important_JJ pathogen_NN in_IN nosocomial_JJ infections_NNS of_IN immunocompromised_JJ patients_NNS suffering_VBG from_IN cancer_NN ,_, cystic_JJ fibrosis_NN ,_, drug_NN addition_NN ,_, AIDS_NP and_CC in_IN patients_NNS with_IN organ_NN transplants_NNS and_CC on_IN dialysis_NN ._SENT This_DT organism_NN is_VBZ inherently_RB resistant_JJ to_TO most_JJS antibiotics_NNS due_JJ to_TO its_PP$ low_JJ outer_JJ membrane_NN permeability_NN and_CC to_TO beta-lactam_JJ containing_VBG antibiotics_NNS due_JJ to_TO the_DT production_NN of_IN a_DT chromosomally_RB expressed_VBN group_NN 2e_JJ beta-lactamase_NN (_( L2_NP )_) and_CC a_DT group_NN 3c_JJ beta-lactamase_NN (_( L1_NP )_) ._SENT L1_NP has_VBZ been_VBN cloned_VBN ,_, over-expressed_VBN ,_, and_CC partially_RB characterized_VBN by_IN kinetic_JJ and_CC crystallographic_JJ studies_NNS ._SENT The_DT enzyme_NN exists_VBZ as_IN a_DT homotetramer_NN of_IN ca_MD ._SENT 118_CD kDa_NN in_IN solution_NN and_CC in_IN the_DT crystalline_JJ state_NN ._SENT The_DT enzyme_NN tightly_RB binds_VBZ two_CD Zn(II)_NP ions_NNS per_IN subunit_NN and_CC requires_VBZ both_DT Zn(II)_NP ions_NNS for_IN full_JJ catalytic_JJ activity_NN ._SENT The_DT Zn1_NP site_NN has_VBZ 3_CD histidine_NN residues_NNS and_CC 1_CD bridging_NN hydroxide_NN as_IN ligands_NNS ,_, and_CC the_DT Zn2_NP site_NN has_VBZ 2_CD histidines_NNS ,_, 1_LS aspartic_JJ acid_NN ,_, 1_CD terminally-bound_JJ water_NN ,_, and_CC the_DT bridging_VBG hydroxide_NN as_IN ligands_NNS ._SENT Spencer_NP and_CC coworkers_NNS used_VBD the_DT crystal_NN structure_NN and_CC modeling_NN studies_NNS to_TO propose_VB a_DT substrate_NN binding_VBG model_NN and_CC identified_VBN several_JJ active_JJ site_NN residues_NNS that_WDT were_VBD involved_VBN in_IN substrate_NN binding_NN ._SENT However_RB ,_, this_DT model_NN has_VBZ not_RB been_VBN tested_VBN experimentally_RB ._SENT In_IN order_NN to_TO prepare_VB tight_JJ binding_JJ inhibitors_NNS of_IN the_DT metallo-beta-lactamases_NNS ,_, knowledge_NN about_IN how_WRB substrate_NN binds_VBZ to_TO the_DT enzymes_NNS is_VBZ needed_VBN so_RB that_IN all_DT substrate-enzyme_NN binding_VBG contacts_NNS can_MD be_VB maintained_VBN in_IN any_DT proposed_VBN inhibitor_NN ._SENT This_DT work_NN describes_VBZ our_PP$ efforts_NNS at_IN understanding_NN how_WRB substrates_NNS bind_VBP to_TO metallo-beta-lactamase_VB L1_NP ._SENT Several_JJ site-directed_JJ mutants_NNS of_IN L1_NP were_VBD generated_VBN and_CC characterized_VBN ,_, and_CC the_DT results_NNS from_IN these_DT studies_NNS reveal_VBP that_IN none_NN of_IN the_DT active_JJ site_NN residues_NNS predicted_VBD from_IN earlier_RBR computational_JJ studies_NNS are_VBP essential_JJ for_IN tight_JJ substrate_NN binding_NN ._SENT Figure_NP 1_CD |_SYM Active_JJ site_NN residues_NNS that_WDT were_VBD mutated_VBN in_IN this_DT study_NN ._SENT Active_JJ site_NN residues_NNS that_WDT were_VBD mutated_VBN in_IN this_DT study_NN ._SENT Figure_NN was_VBD rendered_VBN using_VBG Rasmol_NP v._IN 2.6_CD ._SENT The_DT coordinates_NNS were_VBD obtained_VBN from_IN the_DT Protein_NP Data_NP Bank_NP using_VBG the_DT accession_NN number_NN 1_CD sml_NN ._SENT Wild_JJ type_NN L1_NP |_SYM Wild-type_NP L1_NP was_VBD over-expressed_VBN in_IN Escherichia_NP coli_NNS and_CC purified_VBD as_RB previously_RB described_VBN ._SENT This_DT procedure_NN produced_VBD an_DT average_NN of_IN 50_CD --_: 60_CD mg_NN of_IN >90_JJ %_NN pure_JJ ,_, active_JJ protein_NN per_IN 4_CD L_NN of_IN growth_NN culture_NN ._SENT Circular_JJ dichroism_NN spectra_NN were_VBD collected_VBN on_IN wild-type_NN samples_NNS to_TO ensure_VB L1_NP expressed_VBD using_VBG the_DT pET26b_NN expression_NN system_NN had_VBD the_DT correct_JJ secondary_JJ structure_NN ._SENT The_DT CD_NN spectrum_NN of_IN wild_JJ type_NN L1_NP showed_VBD an_DT intense_JJ ,_, broad_JJ feature_NN at_IN 190_CD nm_NN and_CC a_DT smaller_JJR feature_NN at_IN 215_CD nm_NN (_( see_VB Additional_JJ file_NN 1_CD :_: CD_NN spectra_NN )_) ._SENT These_DT features_NNS are_VBP consistent_JJ with_IN a_DT sample_NN with_IN significant_JJ alpha/beta_NN content_NN ._SENT The_DT Compton_NP and_CC Johnson_NP algorithm_NN was_VBD used_VBN to_TO estimate_VB secondary_JJ structure_NN in_IN the_DT samples_NNS ;_: wild-type_NP L1_NP was_VBD estimated_VBN to_TO have_VB 38.3_CD %_NN alpha-helix_NN ,_, 26.7_CD %_NN beta-structure_NN (_( 9.3_CD %_NN antiparallel_JJ beta-sheet_NN ,_, 2.1_CD %_NN parallel_JJ beta-sheet_NN ,_, and_CC 15.3_CD %_NN beta-turn_NN )_) ,_, and_CC 34.9_CD %_NN other_JJ structure_NN ._SENT These_DT estimates_NNS are_VBP in_IN excellent_JJ agreement_NN with_IN the_DT crystallographically_RB determined_VBN secondary_JJ structure_NN of_IN ~40_JJ %_NN alpha-helix_NN and_CC 30_CD %_NN beta-structure_NN ._SENT Metal_NN analyses_NNS on_IN multiple_JJ preparations_NNS of_IN wild-type_NP L1_NP demonstrated_VBD that_IN the_DT enzyme_NN binds_VBZ 1.9_CD +-_NN 0.2_CD Zn(II)_NP ions_NNS per_IN monomer_NN ,_, in_IN agreement_NN with_IN previous_JJ results_NNS ._SENT Table_NP 2_CD |_SYM Metal_NP Content_NP of_IN Wild-type_NP L1_NP and_CC L1_NP mutants_NNS Steady_NP state_NN kinetic_JJ studies_NNS were_VBD performed_VBN on_IN multiple_JJ preparations_NNS of_IN wild_JJ type_NN L1_NP ,_, and_CC the_DT resulting_VBG kinetic_JJ data_NNS are_VBP shown_VBN in_IN Tables_NP ,_, ,_, ._SENT When_WRB using_VBG nitrocefin_NN as_IN substrate_NN and_CC 50_CD mM_NNS cacodylate_JJ ,_, pH_NN 7.0_CD ,_, as_IN buffer_NN ,_, wild-type_NP L1_NP exhibited_VBD a_DT kcat_NN value_NN of_IN 38_CD +-_NN 1_CD s-1_NN and_CC a_DT Km_NP value_NN of_IN 12_CD +-_NN 1_CD muM_NN ._SENT The_DT inclusion_NN of_IN 100_CD muM_NN ZnCl2_NN in_IN the_DT assay_NN buffer_NN resulted_VBD in_IN slightly_RB lower_JJR values_NNS of_IN Km_NP and_CC higher_JJR values_NNS for_IN kcat_NN ._SENT The_DT inclusion_NN of_IN higher_JJR concentrations_NNS of_IN Zn(II)_NP did_VBD not_RB further_RBR affect_VB the_DT steady-state_NN kinetic_JJ constants_NNS ._SENT Apparently_RB ,_, the_DT purified_VBN ,_, recombinant_JJ enzyme_NN does_VBZ not_RB bind_VB its_PP$ full_JJ complement_NN of_IN Zn(II)_NP ;_: therefore_RB ,_, 100_CD muM_NN Zn(II)_NP was_VBD included_VBN in_IN all_DT subsequent_JJ kinetic_JJ studies_NNS ._SENT Table_NP 3_CD |_SYM Steady-state_JJ kinetic_JJ constants_NNS for_IN hydrolysis_NN of_IN cephalosporins_NNS by_IN wild-type_NP L1_NP and_CC L1_NP mutants_NNS ._SENT Table_NP 4_CD |_SYM Steady-state_JJ kinetic_JJ constants_NNS for_IN hydrolysis_NN of_IN penicillins_NNS by_IN wild-type_NP L1_NP and_CC L1_NP mutants_NNS ._SENT Table_NP 5_CD |_SYM Steady-state_JJ kinetic_JJ constants_NNS for_IN hydrolysis_NN of_IN carbapenems_NNS by_IN wild-type_NP L1_NP and_CC L1_NP mutants_NNS Wild-type_NP L1_NP exhibited_VBD kcat_NN values_NNS of_IN 41_CD +-_NN 1_CD s-1_NN ,_, 1.9_CD +-_NN 0.1_CD s-1_NN ,_, 42_CD +-_NN 1_CD s-1_NN ,_, and_CC 82_CD +-_NN 5_CD s-1_NN for_IN the_DT cephalosporins_NNS ,_, nitrocefin_NN ,_, cefoxitin_NN ,_, cefaclor_NN ,_, and_CC cephalothin_NN ._SENT For_IN these_DT same_JJ substrates_NNS ,_, the_DT Km_NP values_NNS were_VBD 4_CD +-_NN 1_CD muM_NN ,_, 1.1_CD +-_NN 0.1_CD muM_NN ,_, 13_CD +-_NN 1_CD muM_NN ,_, and_CC 8.9_CD +-_NN 1.5_CD muM_NN ,_, respectively_RB ._SENT Two_CD penicillins_NNS were_VBD tested_VBN as_IN substrates_NNS ,_, and_CC penicillin_NN G_NN and_CC ampicillin_NN exhibited_VBN Km_NP values_NNS of_IN 38_CD +-_NN 12_CD muM_NN and_CC 55_CD +-_NN 5_CD muM_NN and_CC kcat_NN values_NNS of_IN 600_CD +-_NN 100_CD s-1_NN and_CC 520_CD +-_NN 10_CD s-1_NN ,_, respectively_RB ._SENT Three_CD carbapenems_NNS were_VBD also_RB used_VBN as_IN substrates_NNS for_IN L1_NP ,_, and_CC biapenem_NN ,_, imipenem_NN ,_, and_CC meropenem_NN exhibited_VBN Km_NP values_NNS of_IN 32_CD +-_NN 1_CD muM_NN ,_, 57_CD +-_NN 7_CD muM_NN ,_, and_CC 15_CD +-_NN 4_CD muM_NN and_CC kcat_NN values_NNS of_IN 134_CD +-_NN 4_CD s-1_NN ,_, 370_CD +-_NN 5_CD s-1_NN ,_, and_CC 157_CD +-_NN 9_CD s-1_NN ,_, respectively_RB ._SENT L1_NP 's_POS preference_NN for_IN penicillins_NNS and_CC carbapenems_NNS over_IN cephalosporins_NNS ,_, as_RB exemplified_VBN by_IN the_DT kcat_NN values_VBZ ,_, is_VBZ in_IN agreement_NN with_IN previous_JJ studies_NNS and_CC supports_VBZ L1_NP 's_POS placement_NN in_IN the_DT beta-lactamase_JJ 3c_JJ family_NN ._SENT Rapid-scanning_NP visible_JJ spectra_NN of_IN 25_CD muM_NN wild-type_NN L1_NP with_IN 5_CD muM_NN nitrocefin_NN demonstrated_VBD a_DT decrease_NN in_IN absorbance_NN at_IN 390_CD nm_NN ,_, an_DT increase_NN at_IN 485_CD nm_NN ,_, and_CC a_DT rapid_JJ increase_NN and_CC slower_JJR decrease_NN in_IN absorbance_NN at_IN 665_CD nm_NN ._SENT These_DT spectra_NN are_VBP similar_JJ to_TO those_DT previously_RB reported_VBN for_IN wild-type_NP L1_NP and_CC nitrocefin_NP ,_, and_CC the_DT features_NNS can_MD be_VB attributed_VBN to_TO substrate_NN decay_NN ,_, product_NN formation_NN ,_, and_CC intermediate_JJ formation_NN and_CC decay_NN ,_, respectively_RB ._SENT Under_IN these_DT conditions_NNS ,_, 2.2_CD muM_NN intermediate_NN was_VBD formed_VBN during_IN the_DT first_JJ 10_CD milliseconds_NNS of_IN the_DT reaction_NN ,_, and_CC the_DT rate_NN of_IN decay_NN of_IN this_DT intermediate_NN corresponds_VBZ to_TO the_DT steady-state_NN kcat_NN ._SENT To_TO probe_VB further_RBR the_DT binding_NN of_IN nitrocefin_NN to_TO wild-type_NP L1_NP ,_, stopped-flow_NN fluorescence_NN studies_NNS were_VBD conducted_VBN as_IN previously_RB described_VBN ._SENT The_DT reaction_NN of_IN wild-type_NN L1_JJ with_IN nitrocefin_NN under_IN steady-state_NN conditions_NNS at_IN 10C_NP resulted_VBD in_IN a_DT rapid_JJ decrease_NN in_IN fluorescence_NN followed_VBN by_IN a_DT rate-limiting_JJ return_NN of_IN fluorescence_NN ._SENT Fitting_VBG of_IN the_DT data_NNS ,_, as_RB described_VBN by_IN Spencer_NP et_FW al._FW ,_, resulted_VBN in_IN a_DT KS_NP value_NN for_IN wild-type_NP L1_NP of_IN 38_CD +-_NN 5_CD muM_NN ._SENT Figure_NP 2_CD |_SYM Intermediate_NP formation_NN by_IN wild-type_NP L1_NP and_CC L1_NP mutants_NNS ._SENT Intermediate_JJ formation_NN by_IN wild-type_NP L1_NP and_CC L1_NP mutants_NNS ._SENT The_DT spectra_NN were_VBD collected_VBN using_VBG rapid_JJ scanning_VBG Vis_NP studies_NNS ,_, and_CC the_DT absorbance_NN values_VBZ at_IN 668_CD nm_NN were_VBD converted_VBN to_TO concentration_NN values_NNS as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Typical_JJ reactions_NNS were_VBD conducted_VBN with_IN 25_CD muM_NN L1_NP (_( or_CC mutant_JJ )_) and_CC 5_CD muM_NN nitrocefin_NN in_IN 50_CD mM_NP cacodylate_NN ,_, pH_NN 7.0_CD ,_, containing_VBG 100_CD muM_NN ZnCl2_NP at_IN 25C_NP ._SENT Figure_NP 3_CD |_SYM (_( A_NP )_) Stopped-flow_NP fluorescence_NN of_IN wild-type_NP L1_NP with_IN nitrocefin_NP ._SENT (_( A_NP )_) Stopped-flow_NP fluorescence_NN of_IN wild-type_NN L1_JJ with_IN nitrocefin_NN ._SENT In_IN a_DT typical_JJ reaction_NN ,_, 5_CD --_: 10_CD muM_NN wild-type_NN L1_NP was_VBD mixed_VBN with_IN various_JJ concentrations_NNS of_IN nitrocefin_NN ,_, and_CC the_DT reaction_NN was_VBD monitored_VBN for_IN up_IN to_TO 1_CD second_NN at_IN 10C_NP ,_, using_VBG the_DT conditions_NNS described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT data_NNS were_VBD fitted_VBN to_TO a_DT double_JJ exponential_NN using_VBG SigmaPlot_NP v._CC 6.10.(B)_JJ Plot_NP of_IN observed_JJ rate_NN constant_JJ versus_IN concentration_NN of_IN nitrocefin_NN ._SENT Solid_JJ lines_NNS were_VBD fitted_VBN to_TO the_DT data_NNS as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Ser224_JJ mutants_NNS |_SYM (_( the_DT BBL_NP numbering_VBG scheme_NN proposed_VBN in_IN reference_NN 41_CD was_VBD used_VBN throughout_IN this_DT manuscript_NN )_) ._SENT All_DT sequenced_JJ subclass_NN Ba_NP and_CC Bb_NP metallo-beta-lactamases_NNS (_( except_IN VIM-1_NP )_) have_VBP a_DT lysine_NN residue_NN at_IN position_NN 224_CD ,_, and_CC all_DT computational_JJ models_NNS for_IN substrate_NN binding_VBG to_TO the_DT metallo-beta-lactamases_NNS assume_VBP that_IN the_DT invariant_JJ carboxylate_NN on_IN substrates_NNS forms_VBZ an_DT electrostatic_JJ interaction_NN with_IN this_DT lysine_NN ._SENT In_IN L1_NP ,_, the_DT residue_NN at_IN position_NN 224_CD is_VBZ a_DT serine_NN ,_, and_CC the_DT substrate-binding_JJ model_NN for_IN L1_NP predicts_VBZ that_IN this_DT serine_NN residue_NN interacts_VBZ with_IN the_DT carboxylate_NN on_IN substrate_NN via_IN a_DT water_NN molecule_NN ._SENT To_TO test_VB the_DT proposed_VBN role_NN of_IN Ser224_NP in_IN L1_NP ,_, serine_NN was_VBD changed_VBN to_TO an_DT alanine_NN (_( S224A_NP )_) ,_, aspartic_JJ acid_NN (_( S224D_NP )_) ,_, and_CC lysine_NN (_( S224K_NP )_) ,_, and_CC these_DT mutants_NNS were_VBD characterized_VBN using_VBG metal_NN analyses_NNS ,_, CD_NN spectroscopy_NN ,_, steady-state_NN kinetics_NNS ,_, and_CC pre-steady_JJ state_NN kinetic_JJ studies_NNS ._SENT Small-scale_JJ growth_NN cultures_NNS showed_VBD that_IN all_DT three_CD mutants_NNS were_VBD over-expressed_VBN at_IN levels_NNS comparable_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Large-scale_JJ over-expression_NN and_CC purification_NN of_IN the_DT mutants_NNS showed_VBD that_IN all_DT three_CD mutants_NNS were_VBD isolatable_JJ at_IN levels_NNS comparable_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Metal_NN analyses_NNS of_IN the_DT S224A_NP and_CC S224D_NP mutants_NNS showed_VBD that_IN both_DT mutants_NNS bind_VBP nearly_RB two_CD Zn(II)_NP ions_NNS ,_, like_IN wild-type_NP L1_NP ;_: however_RB ,_, the_DT S224K_NP mutant_NN binds_VBZ only_RB 1.0_CD Zn(II)_NN per_IN protein_NN ._SENT CD_NN spectra_NN of_IN the_DT mutants_NNS were_VBD similar_JJ to_TO those_DT of_IN wild-type_NP L1_NP (_( see_VB Figure_NN in_IN Additional_JJ materials_NNS )_) ._SENT Steady-state_NN kinetic_JJ studies_NNS were_VBD conducted_VBN with_IN all_DT three_CD mutants_NNS in_IN buffer_NN containing_VBG 100_CD muM_NN ZnCl2_JJ to_TO ensure_VB that_IN both_DT Zn(II)_NP binding_JJ sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._SENT Addition_NN of_IN higher_JJR concentrations_NNS of_IN Zn(II)_NP did_VBD not_RB result_VB in_IN different_JJ values_NNS for_IN the_DT steady-state_NN kinetic_JJ constants_NNS in_IN Tables_NP ,_, ,_, ._SENT When_WRB the_DT cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT S224A_NP and_CC S224K_NP mutants_NNS exhibited_VBD 2-_CD to_TO 4-fold_JJ changes_NNS in_IN Km_NP values_NNS ._SENT In_IN studies_NNS with_IN cefoxitin_NN ,_, cefaclor_NN ,_, and_CC cephalothin_NN as_IN substrate_NN ,_, the_DT observed_JJ kcat_NN values_NNS for_IN the_DT S224A_NP and_CC S224K_NP mutants_NNS were_VBD 2-_CD to_TO 7-fold_NN lower_JJR ;_: however_RB ,_, the_DT kcat_NN values_VBZ when_WRB using_VBG nitrocefin_NN as_IN substrate_NN were_VBD slightly_RB higher_JJR (_( <_2-fold). 10-fold_NN decreases_NNS in_IN kcat_NN when_WRB using_VBG the_DT penicillins_NNS as_IN substrates_NNS ._SENT When_WRB the_DT carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS however_RB ,_, the_DT changes_NNS in_IN Km_NP values_NNS were_VBD relatively_RB smaller_JJR than_IN with_IN the_DT other_JJ substrates_NNS ,_, and_CC 2-_CD to_TO 37-fold_JJ changes_NNS in_IN kcat_NN were_VBD observed_VBN ._SENT Rapid-scanning_NP Vis_NP studies_NNS of_IN the_DT S224X_NP mutants_NNS were_VBD conducted_VBN to_TO probe_VB whether_IN the_DT mutations_NNS caused_VBD changes_NNS in_IN the_DT amount_NN of_IN intermediate_JJ that_WDT accumulates_VBZ during_IN catalysis_NN ._SENT When_WRB 50_CD muM_NN S224A_NP was_VBD reacted_VBN with_IN 5_CD muM_NN nitrocefin_NN ,_, 1.7_CD muM_NN intermediate_NN formed_VBN during_IN the_DT first_JJ 10_CD milliseconds_NNS of_IN the_DT reaction_NN ,_, and_CC rate_NN of_IN decay_NN of_IN this_DT intermediate_NN was_VBD equal_JJ to_TO the_DT steady-state_NN kcat_NN ._SENT In_IN spite_NN of_IN utilizing_VBG a_DT number_NN of_IN reaction_NN conditions_NNS ,_, the_DT S224K_NP and_CC S224D_NP mutants_NNS yielded_VBD rapid-scan_JJ spectra_NN with_IN no_DT detectable_JJ absorbances_NNS at_IN 665_CD nm_NN ,_, indicating_VBG that_IN the_DT intermediate_NN is_VBZ not_RB stabilized_VBN as_RB well_RB in_IN these_DT mutants_NNS as_IN in_IN wild-type_NN L1_NP ._SENT Stopped-flow_NP fluorescence_NN studies_NNS at_IN 10C_NP with_IN the_DT S224A_NP ,_, S224D_NP ,_, and_CC S224K_NP mutants_NNS and_CC nitrocefin_NN as_IN the_DT substrate_NN resulted_VBN in_IN KS_NP values_NNS of_IN 39_CD +-_NN 10_CD ,_, 213_CD +-_NN 63_CD ,_, and_CC 33_CD +-_NN 5_CD muM_NN ,_, respectively_RB ._SENT Asn233_JJ mutants_NNS |_SYM Two-thirds_NNS of_IN all_DT sequenced_JJ metallo-beta-lactamases_NNS have_VBP an_DT Asn_NP at_IN position_NN 233_CD ,_, and_CC this_DT residue_NN was_VBD predicted_VBN and_CC shown_VBN to_TO be_VB involved_VBN with_IN substrate_NN binding_NN and_CC activation_NN by_IN interacting_VBG electrostatically_RB with_IN the_DT substrate_NN beta-lactam_NN carbonyl_NN ._SENT However_RB ,_, in_IN L1_NP ,_, Asn233_NP is_VBZ 14_CD A_DT away_RB from_IN the_DT modeled_VBN position_NN of_IN the_DT substrate_NN beta-lactam_NN carbonyl_NN ._SENT To_TO test_VB the_DT role_NN of_IN Asn233_NP in_IN substrate_NN binding_NN ,_, the_DT Asn_NP was_VBD changed_VBN to_TO a_DT leucine_NN (_( N233L_NP )_) and_CC to_TO an_DT aspartic_JJ acid_NN (_( N233D_NP )_) ,_, and_CC these_DT mutants_NNS were_VBD characterized_VBN by_IN using_VBG metal_NN analyses_NNS ,_, CD_NN spectroscopy_NN ,_, steady-state_NN kinetics_NNS ,_, and_CC pre-steady_JJ state_NN kinetic_JJ studies_NNS ._SENT Small-scale_JJ growth_NN cultures_NNS showed_VBD that_IN both_DT mutants_NNS were_VBD over-expressed_VBN at_IN levels_NNS comparable_JJ to_TO that_DT of_IN wild-type_NP L1_NP ._SENT Large-scale_JJ over-expression_NN and_CC purification_NN of_IN the_DT mutants_NNS showed_VBD that_IN both_DT mutants_NNS were_VBD isolatable_JJ at_IN levels_NNS comparable_JJ to_TO that_DT of_IN wild-type_NP L1_NP ._SENT Metal_NN analyses_NNS of_IN the_DT N233L_NP and_CC N233D_NP mutants_NNS showed_VBD that_IN both_DT bind_NN nearly_RB two_CD Zn(II)_NP ions_NNS ,_, like_IN wild-type_NN L1_NP ._SENT CD_NN spectra_NN of_IN the_DT mutants_NNS were_VBD similar_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Steady-state_NN kinetic_JJ studies_NNS were_VBD conducted_VBN with_IN both_DT mutants_NNS in_IN buffer_NN containing_VBG 100_CD muM_NN ZnCl2_JJ to_TO ensure_VB that_IN both_DT Zn(II)_NP binding_JJ sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._SENT Addition_NN of_IN higher_JJR concentrations_NNS of_IN Zn(II)_NP did_VBD not_RB result_VB in_IN different_JJ values_NNS for_IN the_DT steady-state_NN kinetic_JJ constants_NNS in_IN Tables_NP ,_, ,_, ._SENT With_IN all_DT substrates_NNS tested_VBD ,_, the_DT N233L_NP and_CC N233D_JJ mutants_NNS exhibited_VBN Km_NP values_NNS that_WDT differed_VBD less_JJR than_IN a_DT factor_NN of_IN 4_CD than_IN that_WDT observed_VBD for_IN wild-type_NP L1_NP (_( Tables_NP ,_, ,_, )_) ._SENT The_DT kcat_NN values_NNS exhibited_VBN by_IN these_DT mutants_NNS for_IN all_DT substrates_NNS also_RB differed_VBD by_IN less_JJR than_IN a_DT factor_NN of_IN 4_CD ,_, except_IN when_WRB biapenem_NN and_CC meropenem_NN were_VBD used_VBN as_IN substrates_NNS for_IN the_DT N233D_JJ mutant_NN ._SENT With_IN these_DT two_CD substrates_NNS ,_, there_EX was_VBD a_DT 19-fold_NN and_CC 45-fold_JJ decrease_NN in_IN the_DT kcat_NN values_VBZ when_WRB using_VBG biapenem_NN and_CC meropenem_NN ,_, respectively_RB ._SENT The_DT steady-state_NN kinetic_JJ data_NNS generally_RB support_VBP the_DT prediction_NN that_IN Asn233_NP does_VBZ not_RB play_VB a_DT large_JJ role_NN in_IN binding_VBG or_CC catalysis_NN ._SENT However_RB ,_, rapid-scanning_VBG Vis_NP studies_NNS of_IN N233L_NP and_CC N233D_NP with_IN nitrocefin_NP demonstrate_VBP that_IN no_DT detectable_JJ amounts_NNS of_IN intermediate_JJ are_VBP formed_VBN during_IN the_DT reaction_NN ,_, even_RB when_WRB using_VBG a_DT wide_JJ number_NN of_IN reaction_NN conditions_NNS ._SENT Stopped-flow_JJ fluorescence_NN studies_NNS at_IN 10C_NP with_IN the_DT N233L_NP and_CC N233D_JJ mutants_NNS and_CC nitrocefin_NN as_IN substrate_NN resulted_VBN in_IN KS_NP values_NNS of_IN 26_CD +-_NN 9_CD and_CC 25_CD +-_NN 8_CD muM_NN ,_, respectively_RB ._SENT Tyr228_JJ mutants_NNS |_SYM The_DT substrate-binding_NN model_NN showed_VBD that_IN Tyr228_NP in_IN L1_NP was_VBD position-conserved_VBN with_IN Asn233_NP in_IN the_DT other_JJ crystallographically_RB characterized_VBN metallo-beta-lactamases_NNS [_SYM ,,-_NN ]_SYM ._SENT Spencer_NP and_CC coworkers_NNS postulated_VBD that_IN Tyr228_NP is_VBZ part_NN of_IN an_DT oxyanion_NN hole_NN that_WDT interacts_VBZ with_IN the_DT beta-lactam_NN carbonyl_NN on_IN substrate_NN and_CC helps_VBZ to_TO stabilize_VB the_DT putative_JJ tetrahedral_JJ intermediate_NN formed_VBN during_IN substrate_NN turnover_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, Tyr228_NP was_VBD changed_VBN to_TO an_DT alanine_NN and_CC to_TO a_DT phenylalanine_NN to_TO afford_VB the_DT Y228A_NP and_CC Y228F_NP mutants_NNS ,_, respectively_RB ._SENT Small-scale_JJ growth_NN cultures_NNS showed_VBD that_IN both_DT mutants_NNS were_VBD over-expressed_VBN at_IN levels_NNS comparable_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Large-scale_JJ over-expression_NN and_CC purification_NN of_IN the_DT Y228A_NP and_CC Y228F_NP mutants_NNS showed_VBD that_IN both_DT mutants_NNS were_VBD isolatable_JJ at_IN levels_NNS comparable_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Metal_NN analyses_NNS of_IN the_DT mutants_NNS showed_VBD that_IN both_DT bind_NN nearly_RB two_CD Zn(II)_NP ions_NNS ,_, like_IN wild-type_NP L1_NP ,_, and_CC CD_NN spectra_NN of_IN the_DT mutants_NNS were_VBD similar_JJ to_TO those_DT of_IN wild-type_NP L1_NP ._SENT Steady-state_NN kinetic_JJ studies_NNS were_VBD conducted_VBN with_IN both_DT mutants_NNS in_IN buffer_NN containing_VBG 100_CD muM_NN ZnCl2_JJ to_TO ensure_VB that_IN both_DT Zn(II)_NP binding_JJ sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._SENT Addition_NN of_IN higher_JJR concentrations_NNS of_IN Zn(II)_NP did_VBD not_RB result_VB in_IN different_JJ values_NNS for_IN the_DT steady-state_NN kinetic_JJ constants_NNS in_IN Tables_NP ,_, ,_, ._SENT When_WRB cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT Y228A_NP and_CC Y228F_NP mutants_NNS exhibited_VBD Km_NP values_NNS that_WDT were_VBD 6-_CD to_TO 45-fold_NN higher_JJR than_IN those_DT observed_VBN for_IN wild-type_NP L1_NP ._SENT The_DT largest_JJS change_NN in_IN Km_NP was_VBD observed_VBN when_WRB cefaclor_NN was_VBD used_VBN as_IN substrate_NN ,_, and_CC the_DT smallest_JJS change_NN was_VBD observed_VBN when_WRB nitrocefin_NN was_VBD used_VBN as_IN substrate_NN ._SENT The_DT Tyr228_NP mutants_NNS exhibited_VBN <_SYM 4-fold_JJ change_NN in_IN kcat_NN values_NNS for_IN the_DT cephalosporins_NNS tested_VBD ,_, suggesting_VBG that_IN Tyr228_NP is_VBZ not_RB playing_VBG a_DT large_JJ role_NN in_IN catalysis_NN ._SENT When_WRB penicillins_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT Tyr228_NP mutants_NNS exhibited_VBD 3-_CD to_TO 13-fold_NN increased_VBD Km_NP values_VBZ and_CC <_SYM 2-fold_JJ changes_NNS in_IN kcat_NN ,_, as_RB compared_VBN to_TO the_DT values_NNS ascertained_VBD using_VBG wild-type_NP L1_NP ._SENT On_IN the_DT other_JJ hand_NN when_WRB carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT Tyr228_NP mutants_NNS exhibited_VBN <_SYM 6-fold_JJ increases_NNS in_IN Km_NP values_NNS as_RB compared_VBN to_TO those_DT values_NNS for_IN wild-type_NN L1_NP ._SENT Interestingly_RB ,_, there_EX was_VBD a_DT 2-_CD to_TO 8-fold_JJ drop_NN in_IN kcat_NN values_NNS for_IN the_DT Tyr228_NP mutants_NNS ,_, as_RB compared_VBN to_TO values_NNS observed_VBN for_IN wild-type_NP L1_NP ,_, when_WRB using_VBG the_DT carbapenems_NNS as_IN substrates_NNS ._SENT Rapid-scanning_NP Vis_NP spectra_NN of_IN the_DT reaction_NN of_IN the_DT Y228A_NP and_CC Y228F_NP mutants_NNS with_IN nitrocefin_NN demonstrated_VBD a_DT marked_JJ decrease_NN in_IN the_DT amount_NN of_IN intermediate_JJ formed_VBN with_IN these_DT mutants_NNS ._SENT In_IN reactions_NNS with_IN 50_CD muM_NN mutant_NN and_CC 5_CD muM_NN nitrocefin_NN ,_, only_RB 0.75_CD and_CC <_SYM 0.30_CD muM_NN intermediate_NN formed_VBN for_IN the_DT Y228F_NP and_CC Y228A_NP mutants_NNS ,_, respectively_RB ._SENT The_DT concentration_NN of_IN mutants_NNS were_VBD varied_VBN between_IN 25_CD to_TO 150_CD muM_NN to_TO ensure_VB that_IN all_DT of_IN the_DT substrate_NN was_VBD bound_VBN ;_: however_RB ,_, none_NN of_IN the_DT reactions_NNS resulted_VBN in_IN the_DT detection_NN of_IN intermediate_JJ at_IN levels_NNS observed_VBN for_IN wild-type_NP L1_NP (_( data_NN not_RB shown_VBN )_) ._SENT Stopped-flow_JJ fluorescence_NN studies_NNS at_IN 10C_NN of_IN nitrocefin_NN hydrolysis_NN by_IN Y191A_NP and_CC Y191F_NP resulted_VBD in_IN KS_NP values_NNS of_IN 85_CD +-_NN 9_CD and_CC 22_CD +-_NN 6_CD muM_NN ,_, respectively_RB ._SENT Ile164_NP and_CC Phe158_NP mutants_NNS |_SYM All_DT crystallographically_RB characterized_VBN metallo-beta-lactamases_NNS have_VBP a_DT flexible_JJ amino_NN acid_NN chain_NN that_WDT extends_VBZ over_IN the_DT active_JJ site_NN [_SYM ,,-_NN ]_SYM ._SENT Previous_JJ NMR_NP studies_NNS on_IN CcrA_NP have_VBP shown_VBN that_IN this_DT loop_NN "_`` clamps_VBZ down_RP "_'' on_IN substrate_NN or_CC inhibitor_NN upon_IN binding_JJ ,_, and_CC there_EX is_VBZ speculation_NN that_IN the_DT distortion_NN of_IN substrate_NN upon_IN clamping_VBG down_RP of_IN the_DT loop_NN may_MD drive_VB catalysis_NN ._SENT The_DT crystal_NN structure_NN of_IN L1_NP showed_VBD that_IN there_EX is_VBZ a_DT large_JJ loop_NN that_WDT extends_VBZ over_IN the_DT active_JJ site_NN ,_, and_CC modeling_NN studies_NNS have_VBP predicted_VBN that_IN two_CD residues_NNS ,_, Ile164_NP and_CC Phe158_NP ,_, make_VBP significant_JJ contacts_NNS with_IN large_JJ ,_, hydrophobic_JJ substituents_NNS at_IN the_DT 2_CD '_POS or_CC 6_CD '_'' positions_NNS on_IN penicillins_NNS ,_, cephalosporins_NNS ,_, or_CC carbapenems_NNS ._SENT To_TO test_VB this_DT prediction_NN ,_, Ile_NP 164_CD and_CC Phe158_NP were_VBD changed_VBN from_IN large_JJ ,_, hydrophobic_JJ residues_NNS to_TO alanines_NNS to_TO afford_VB the_DT I164A_NP and_CC F158A_NP mutants_NNS ._SENT Small-scale_JJ growth_NN cultures_NNS demonstrated_VBD the_DT I164A_NP and_CC F158A_NP mutants_NNS were_VBD over-expressed_VBN at_IN levels_NNS comparable_JJ to_TO that_DT of_IN wild-type_NP L1_NP (_( data_NN not_RB shown_VBN )_) ._SENT Large-scale_JJ over-expression_NN and_CC purification_NN of_IN the_DT mutants_NNS resulted_VBN in_IN comparable_JJ quantities_NNS of_IN isolatable_JJ enzymes_NNS ,_, which_WDT had_VBD identical_JJ CD_NN spectra_NN as_IN wild-type_NP L1_NP and_CC bound_VBN slightly_RB less_JJR Zn(II)_NP than_IN wild-type_NP L1_NP ._SENT All_DT steady-state_NN kinetic_JJ studies_NNS were_VBD conducted_VBN in_IN buffers_NNS containing_VBG 100_CD muM_NN ZnCl2_JJ to_TO ensure_VB that_IN both_DT metal_NN binding_VBG sites_NNS were_VBD saturated_VBN during_IN the_DT studies_NNS ._SENT When_WRB using_VBG the_DT cephalosporins_NNS ,_, nitrocefin_NN ,_, cefoxitin_NN ,_, and_CC cephalothin_NN ,_, as_IN substrates_NNS and_CC the_DT I164A_NP mutant_NN ,_, there_EX were_VBD 2-_CD to_TO 10-fold_NN (_( only_RB for_IN cefoxitin_NN )_) increases_NNS in_IN Km_NP and_CC 2-_CD to_TO 4-fold_JJ increases_NNS in_IN kcat_NN observed_VBD ._SENT However_RB when_WRB cefaclor_NN was_VBD used_VBN as_IN substrate_NN ,_, the_DT I164A_NP mutant_NN exhibited_VBD a_DT 3-fold_JJ decrease_NN in_IN Km_NP and_CC a_DT 1.5-fold_NN decrease_NN in_IN kcat_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, the_DT Km_NP and_CC kcat_NN values_NNS for_IN the_DT I164A_NP mutant_NN when_WRB the_DT penicillins_NNS or_CC carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS were_VBD very_RB similar_JJ to_TO those_DT numbers_NNS exhibited_VBN by_IN wild-type_NP L1_NP (_( Tables_NP and_CC )_) ._SENT When_WRB the_DT cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS for_IN the_DT F158A_NP mutant_NN ,_, the_DT Km_NP values_NNS observed_VBD were_VBD 7-_CD to_TO 31-fold_NN higher_JJR than_IN those_DT determined_VBN for_IN wild-type_NP L1_NP ,_, and_CC surprisingly_RB ,_, the_DT kcat_NN values_NNS were_VBD 2-_CD to_TO 31-fold_NN higher_JJR than_IN those_DT exhibited_VBN by_IN wild-type_NP L1_NP ._SENT As_RB with_IN the_DT I164A_NP mutant_NN ,_, the_DT changes_NNS in_IN Km_NP and_CC kcat_NN for_IN the_DT penicillins_NNS and_CC carbapenems_NNS were_VBD relatively_RB small_JJ ,_, as_RB compared_VBN with_IN the_DT values_NNS obtained_VBN with_IN the_DT cephalosporins_NNS ._SENT Rapid-scanning_NP Vis_NP studies_NNS on_IN nitrocefin_NN hydrolysis_NN by_IN I164A_NP and_CC F158A_NP showed_VBD a_DT marked_JJ decrease_NN in_IN intermediate_JJ accumulation_NN ,_, with_IN the_DT I164A_NP mutant_JJ generating_NN <_SYM 0.30_CD muM_NN intermediate_JJ and_CC the_DT F158A_NP producing_VBG no_DT detectable_JJ intermediate_NN ._SENT Stopped-flow_JJ fluorescence_NN studies_NNS at_IN 10C_NP resulted_VBD in_IN a_DT KS_NP value_NN of_IN 31_CD +-_NN 11_CD muM_NN for_IN the_DT I164A_NP mutant_NN ._SENT The_DT reaction_NN of_IN F158A_NP with_IN nitrocefin_NP was_VBD so_RB rapid_JJ ,_, we_PP could_MD not_RB determine_VB a_DT KS_NP value_NN for_IN this_DT mutant_NN ._SENT beta-Lactam_JJ containing_VBG antibiotics_NNS constitute_VBP the_DT largest_JJS class_NN of_IN antibiotics_NNS ,_, and_CC these_DT compounds_NNS are_VBP relatively_RB inexpensive_JJ to_TO produce_VB ,_, cause_VB minor_JJ side_NN effects_NNS ,_, and_CC are_VBP effective_JJ towards_IN a_DT number_NN of_IN bacterial_JJ strains_NNS ._SENT Nonetheless_RB ,_, bacterial_JJ resistance_NN to_TO these_DT antibiotics_NNS is_VBZ extensive_JJ ,_, most_RBS commonly_RB due_JJ to_TO the_DT bacterial_JJ production_NN of_IN beta-lactamases_NNS ._SENT In_IN fact_NN ,_, there_EX have_VBP been_VBN over_IN 300_CD distinct_JJ beta-lactamases_NNS reported_VBD ,_, and_CC most_JJS of_IN these_DT enzymes_NNS utilize_VBP an_DT active_JJ site_NN serine_NN group_NN to_TO nucleophilically_RB attack_VB the_DT beta-lactam_NN carbonyl_NN ,_, resulting_VBG in_IN a_DT hydrolyzed_VBN product_NN that_WDT is_VBZ covalently_RB attached_VBN to_TO the_DT active_JJ site_NN ._SENT To_TO combat_VB these_DT enzymes_NNS ,_, beta-lactamase_NN inhibitors_NNS such_JJ as_IN clavulanic_JJ acid_NN ,_, sulbactam_NN ,_, and_CC tazobactam_NN have_VBP been_VBN given_VBN in_IN combination_NN with_IN a_DT beta-lactam_NN containing_VBG antibiotic_NN to_TO treat_VB bacterial_JJ infections_NNS ._SENT One_CD class_NN of_IN beta-lactamases_NNS that_WDT are_VBP particularly_RB unaffected_JJ by_IN the_DT known_VBN beta-lactamase_NN inhibitors_NNS and_CC have_VBP been_VBN shown_VBN to_TO hydrolyze_VB almost_RB all_DT known_VBN beta-lactam_NN containing_VBG antibiotics_NNS including_VBG late_JJ generation_NN carbapenems_NNS at_IN high_JJ rates_NNS are_VBP the_DT metallo-beta-lactamases_NNS ._SENT Although_IN there_EX are_VBP no_DT reports_NNS of_IN metallo-beta-lactamases_NNS isolated_VBN from_IN major_JJ pathogens_NNS ,_, these_DT enzymes_NNS are_VBP produced_VBN by_IN pathogens_NNS such_JJ as_IN B._NP fragilis_NP ,_, S._NP maltophilia_NP ,_, and_CC P._NP aeruginosa_NP ._SENT It_PP is_VBZ inevitable_JJ that_IN the_DT continued_JJ and_CC extensive_JJ use_NN of_IN beta-lactam_NN antibiotics_NNS will_MD result_VB in_IN a_DT major_JJ pathogen_NN that_WDT produces_VBZ a_DT metallo-beta-lactamase_NN ._SENT Efforts_NNS to_TO solve_VB the_DT crystal_NN structure_NN of_IN one_CD of_IN the_DT metallo-beta-lactamases_NNS with_IN a_DT bound_JJ substrate_NN molecule_NN have_VBP failed_VBN ,_, most_RBS likely_RB due_JJ to_TO the_DT high_JJ activity_NN of_IN the_DT enzymes_NNS towards_IN all_DT beta-lactam_NN containing_VBG antibiotics_NNS ._SENT Therefore_RB ,_, computational_JJ studies_NNS have_VBP been_VBN used_VBN extensively_RB to_TO study_VB substrate_NN binding_NN ,_, the_DT role_NN of_IN the_DT Zn(II)_NP ions_NNS in_IN catalysis_NN ,_, the_DT protonation_NN state_NN of_IN the_DT active_JJ site_NN ,_, and_CC inhibitor_NN binding_NN [_SYM ,,-_NN ]_SYM ._SENT All_DT of_IN the_DT substrate_NN binding_VBG models_NNS have_VBP made_VBN assumptions_NNS before_IN the_DT substrate_NN was_VBD docked_VBN into_IN the_DT active_JJ site_NN ,_, and_CC some_DT of_IN these_DT assumptions_NNS have_VBP been_VBN shown_VBN to_TO be_VB invalid_JJ for_IN certain_JJ substrates_NNS ._SENT With_IN L1_NP ,_, two_CD key_JJ assumptions_NNS were_VBD made_VBN :_: (_( 1_LS )_) the_DT bridging_VBG hydroxide_NN functions_NNS as_IN the_DT nucleophile_NN during_IN catalysis_NN and_CC (_( 2_LS )_) Zn1_NP coordinates_VBZ the_DT beta-lactam_NN carbonyl_NN ._SENT With_IN these_DT assumptions_NNS and_CC after_IN energy_NN minimizations_NNS ,_, Ser224_NP was_VBD predicted_VBN to_TO hydrogen_NN bond_NN to_TO the_DT substrate_NN carboxylate_NN ,_, reminiscent_JJ of_IN the_DT role_NN predicted_VBD for_IN Lys224_NP in_IN CcrA_NP ._SENT Ullah_NP et_FW al._FW predicted_VBD that_IN Phe158_NP and_CC Ile_NP 164_CD form_NN hydrophobic_JJ interactions_NNS with_IN bulky_JJ substituents_NNS on_IN the_DT substrate_NN ,_, suggesting_VBG that_IN the_DT loss_NN of_IN these_DT residues_NNS would_MD only_RB affect_VB binding_VBG of_IN substrates_NNS with_IN large_JJ aromatic_JJ substituents_NNS ._SENT In_IN the_DT modeling_VBG studies_NNS on_IN CcrA_NP ,_, Asn233_NP was_VBD predicted_VBN to_TO interact_VB with_IN the_DT beta-lactam_NN carbonyl_NN on_IN substrate_NN ,_, and_CC mutagenesis_NN studies_NNS have_VBP supported_VBN this_DT prediction_NN ._SENT Although_IN Asn233_NP is_VBZ sequence_NN conserved_VBN in_IN L1_NP ,_, it_PP is_VBZ located_VBN 14A_JJ away_RB from_IN the_DT modeled_VBN position_NN of_IN the_DT beta-lactam_NN carbonyl_NN and_CC was_VBD predicted_VBN not_RB to_TO play_VB a_DT role_NN in_IN substrate_NN binding_VBG to_TO L1_NP ._SENT On_IN the_DT other_JJ hand_NN ,_, the_DT substrate-binding_NN model_NN predicted_VBD that_IN Tyr228_NP was_VBD in_IN position_NN to_TO offer_VB a_DT hydrogen_NN bond_NN to_TO the_DT beta-lactam_NN carbonyl_NN and_CC participate_VB in_IN an_DT oxyanion_NN hole_NN that_WDT was_VBD proposed_VBN to_TO form_VB as_IN the_DT substrate_NN was_VBD hydrolyzed_VBN ._SENT By_IN using_VBG the_DT crystal_NN structure_NN and_CC modeling_NN studies_NNS on_IN L1_NP ,_, Ullah_NP et_FW al._FW proposed_VBN a_DT reaction_NN mechanism_NN for_IN the_DT enzyme_NN ._SENT To_TO test_VB this_DT proposed_VBN mechanism_NN and_CC the_DT proposed_VBN roles_NNS of_IN the_DT amino_NN acids_NNS discussed_VBN above_IN ,_, site-directed_JJ mutagenesis_NN studies_NNS were_VBD conducted_VBN on_IN metallo-beta-lactamase_NN L1_NP and_CC reported_VBD herein_RB ._SENT The_DT overlap_VBP extension_NN method_NN was_VBD used_VBN to_TO prepare_VB the_DT site-directed_JJ mutants_NNS ,_, and_CC a_DT variety_NN of_IN studies_NNS were_VBD used_VBN to_TO probe_VB whether_IN the_DT single_JJ point_NN mutations_NNS resulted_VBN in_IN large_JJ structural_JJ changes_NNS in_IN the_DT mutant_JJ enzymes_NNS ._SENT (_( 1_LS )_) The_DT over-expression_NN levels_NNS of_IN mutants_NNS were_VBD analyzed_VBN with_IN SDS-PAGE_NP to_TO ensure_VB that_IN the_DT mutations_NNS did_VBD not_RB result_VB in_IN changes_NNS in_IN the_DT over-expression_NN levels_NNS of_IN the_DT enzymes_NNS ._SENT With_IN a_DT few_JJ L1_JJ mutants_NNS and_CC with_IN other_JJ enzyme_NN systems_NNS in_IN the_DT lab_NN ,_, single_JJ point_NN mutations_NNS often_RB result_VBP in_IN depressed_JJ levels_NNS of_IN over-expression_NN ._SENT In_IN the_DT case_NN of_IN the_DT mutants_NNS described_VBD here_RB ,_, all_DT of_IN the_DT mutants_NNS over-expressed_VBN at_IN levels_NNS comparable_JJ to_TO wild-type_VB L1_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT (_( 2_LS )_) The_DT total_JJ amounts_NNS of_IN the_DT mutants_NNS isolatable_JJ after_IN chromatography_NN were_VBD compared_VBN with_IN wild-type_JJ L1_JJ levels_NNS ._SENT We_PP have_VBP found_VBN ,_, in_IN particular_JJ with_IN metal_NN binding_VBG mutants_NNS of_IN L1_NP (_( G._NP Periyannan_NP ,_, R.B._NP Yates_NP ,_, and_CC M.W._NP Crowder_NP ,_, unpublished_JJ results_NNS )_) and_CC glyoxalase_NP II_NP ,_, that_DT single_JJ point_NN mutations_NNS can_MD result_VB in_IN over-expressed_JJ mutants_NNS being_VBG processed_VBN into_IN inclusion_NN bodies_NNS and_CC unisolatable_JJ as_IN soluble_JJ proteins_NNS ._SENT In_IN the_DT case_NN of_IN the_DT mutants_NNS described_VBD here_RB ,_, all_DT of_IN the_DT mutants_NNS were_VBD isolated_VBN at_IN levels_NNS comparable_JJ to_TO wild-type_NN L1_NP ._SENT (_( 3_CD )_) CD_NN spectra_NN were_VBD collected_VBN for_IN all_DT mutants_NNS and_CC compared_VBN to_TO the_DT spectrum_NN of_IN wild-type_NP L1_NP ._SENT Although_IN we_PP did_VBD not_RB expect_VB a_DT large_JJ change_NN in_IN the_DT secondary_JJ structure_NN of_IN L1_NP upon_IN single_JJ point_NN mutations_NNS ,_, CD_NN spectroscopy_NN is_VBZ the_DT most_RBS common_JJ structural_JJ technique_NN to_TO characterize_VB site-directed_JJ mutants_NNS ._SENT All_DT of_IN the_DT mutants_NNS described_VBD here_RB exhibited_VBN CD_NN spectra_NN that_WDT were_VBD very_RB similar_JJ ,_, or_CC identical_JJ ,_, to_TO that_WDT of_IN wild-type_NN L1_NP (_( see_VB Additional_JJ file_NN 1_CD :_: CD_NN spectra_NN )_) ._SENT (_( 4_CD )_) Metal_NN analyses_NNS on_IN the_DT mutants_NNS were_VBD used_VBN to_TO probe_VB whether_IN point_NN mutations_NNS caused_VBD a_DT significant_JJ change_NN to_TO the_DT metal_NN binding_VBG site_NN as_RB to_TO preclude_VB metal_NN binding_NN ._SENT The_DT crystal_NN structures_NNS of_IN the_DT metallo-beta-lactamases_NNS reveal_VBP a_DT complex_JJ and_CC far-reaching_JJ hydrogen-bonding_VBG network_NN around_IN the_DT metal_NN binding_VBG sites_NNS ,_, and_CC disruption_NN of_IN this_DT network_NN is_VBZ predicted_VBN to_TO affect_VB metal_NN binding_NN ._SENT With_IN all_DT of_IN the_DT mutants_NNS described_VBD here_RB except_IN the_DT S224K_NP mutant_NN ,_, each_DT mutant_JJ binds_NNS wild-type_NN or_CC near-wild-type_NN levels_NNS of_IN Zn(II)_NP after_IN purification_NN ._SENT The_DT S224K_NP mutant_NN exhibited_VBD a_DT 50_CD %_NN reduction_NN in_IN metal_NN binding_NN ,_, and_CC we_PP postulate_VBP this_DT is_VBZ due_JJ to_TO electrostatic_JJ repulsions_NNS between_IN the_DT newly_RB introduced_VBN Lys_NP with_IN Zn2_NP ._SENT In_IN spite_NN of_IN the_DT mutants_NNS binding_VBG significant_JJ amounts_NNS of_IN Zn(II)_NP ,_, we_PP included_VBD 100_CD muM_NN ZnCl2_NN in_IN all_DT of_IN the_DT kinetic_JJ buffers_NNS to_TO ensure_VB saturation_NN of_IN the_DT metal_NN binding_VBG sites_NNS and_CC to_TO facilitate_VB direct_JJ comparison_NN of_IN the_DT kinetic_JJ data_NNS ._SENT (_( 5_CD )_) All_DT mutants_NNS were_VBD stable_JJ to_TO multiple_JJ freeze/thaw_NN cycles_NNS and_CC to_TO prolonged_JJ storage_NN (_( >_SYM 3_CD weeks_NNS )_) at_IN 4C_JJ ,_, retaining_VBG >_SYM 95_CD %_NN of_IN their_PP$ activity_NN ._SENT With_IN these_DT five_CD lines_NNS of_IN evidence_NN ,_, we_PP were_VBD confident_JJ that_IN none_NN of_IN the_DT point_NN mutations_NNS resulted_VBN in_IN large_JJ structural_JJ changes_NNS in_IN L1_NP and_CC that_IN any_DT kinetic_JJ differences_NNS could_MD be_VB attributed_VBN to_TO the_DT changed_JJ amino_NN acid_NN ._SENT As_IN a_DT first_JJ approximation_NN of_IN substrate_NN binding_NN ,_, we_PP examined_VBD the_DT steady-state_NN kinetics_NN of_IN 4_CD cephalosporins_NNS ,_, 2_CD penicillins_NNS ,_, and_CC 3_CD carbapenems_NNS (_( Tables_NP ,_, ,_, )_) and_CC compared_VBN the_DT Km_NP values_NNS of_IN the_DT mutants_NNS with_IN those_DT of_IN wild-type_NP L1_NP ._SENT The_DT substrates_NNS tested_VBN were_VBD chosen_VBN because_IN they_PP exhibited_VBD low_JJ Km_NP values_NNS in_IN previous_JJ kinetic_JJ studies_NNS ,_, and_CC we_PP believed_VBD that_IN we_PP could_MD saturate_VB the_DT enzymes_NNS with_IN substrate_NN even_RB if_IN there_EX was_VBD large_JJ change_NN in_IN binding_VBG with_IN the_DT point_NN mutations_NNS ._SENT The_DT Tyr228_NP mutants_NNS exhibited_VBD increased_VBN Km_NP values_NNS for_IN 8_CD of_IN the_DT 9_CD substrates_NNS tested_VBN ,_, with_IN the_DT smallest_JJS changes_NNS in_IN Km_NP observed_VBD when_WRB the_DT carbapenems_NNS were_VBD used_VBN as_IN the_DT substrate_NN ._SENT This_DT result_NN supports_VBZ the_DT proposed_VBN role_NN of_IN Tyr228_NP in_IN substrate_NN binding_NN ._SENT In_IN contrast_NN ,_, the_DT results_NNS on_IN the_DT Ser224_NP mutants_NNS suggest_VBP that_IN this_DT residue_NN is_VBZ not_RB important_JJ in_IN substrate_NN binding_NN ,_, since_IN the_DT S224A_NP and_CC S224K_NP mutants_NNS did_VBD not_RB exhibit_VB any_DT significant_JJ increases_NNS (_( by_IN a_DT factor_NN of_IN >=_NP 10_CD )_) in_IN Km_NP for_IN any_DT of_IN the_DT substrates_NNS tested_VBD ._SENT Only_RB when_WRB Ser224_NP was_VBD replaced_VBN with_IN an_DT Asp_NP residue_NN was_VBD there_RB significant_JJ increases_NNS in_IN the_DT observed_JJ Km_NP value_NN for_IN 6_CD of_IN the_DT 9_CD substrates_NNS tested_VBN ,_, and_CC the_DT largest_JJS changes_NNS were_VBD exhibited_VBN when_WRB the_DT penicillins_NNS were_VBD used_VBN as_IN substrates_NNS ._SENT This_DT result_NN supports_VBZ the_DT observation_NN of_IN differential_JJ binding_JJ modes_NNS of_IN substrates_NNS to_TO the_DT beta-lactamases_NNS ,_, depending_VBG on_IN the_DT structure_NN of_IN the_DT substrate_NN ._SENT The_DT only_JJ remaining_VBG mutants_NNS that_WDT exhibited_VBD significant_JJ changes_NNS in_IN the_DT Km_NP values_NNS were_VBD the_DT I164A_NP and_CC F158A_NP mutants_NNS ._SENT The_DT I164A_NP mutant_NN exhibited_VBD increased_VBN Km_NP values_NNS only_RB when_WRB using_VBG cefoxitin_NN as_IN the_DT substrate_NN ,_, suggesting_VBG an_DT interaction_NN of_IN the_DT isoleucine_NN group_NN with_IN the_DT methoxy_JJ group_NN on_IN cefoxitin_NN ._SENT The_DT F158A_NP mutant_NN exhibited_VBD higher_JJR Km_NP values_NNS when_WRB using_VBG the_DT cephalosporins_NNS as_IN substrates_NNS ,_, suggesting_VBG an_DT interaction_NN of_IN the_DT cephalosporins_NNS '_POS substituents_NNS with_IN the_DT phenylalanine_NN on_IN the_DT loop_NN that_WDT extends_VBZ over_IN the_DT active_JJ site_NN ._SENT None_NN of_IN the_DT other_JJ mutants_NNS exhibited_VBN vastly_RB different_JJ values_NNS for_IN Km_NP with_IN any_DT of_IN the_DT substrates_NNS tested_VBD ._SENT An_DT examination_NN of_IN the_DT kcat_NN values_VBZ of_IN the_DT mutants_NNS revealed_VBD some_DT surprising_JJ results_NNS ._SENT The_DT S224D_NP mutants_NNS displayed_VBD decreased_VBN kcat_NN values_NNS for_IN 7_CD of_IN the_DT 9_CD substrates_NNS tested_VBD ._SENT Since_IN similar_JJ results_NNS were_VBD not_RB observed_VBN with_IN the_DT S224K_NP and_CC S224A_NP mutants_NNS ,_, we_PP 